Table 6.
Quality of life and visual function scores
| Parameter | Ocular Surface Disease Index (OSDI) Score | Visual Function Questionnaire (VFQ) Score | Patient Satisfaction Score (1–10) | Treatment Adherence (%) |
|---|---|---|---|---|
| Group A Baseline | 10.5 ± 3.5 | 80.5 ± 5.5 | 7.5 ± 1.5 | 95% |
| 1 Month | 10.0 ± 3.3 | 82.0 ± 5.2 | 8.0 ± 1.5 | 94% |
| 3 Months | 9.8 ± 3.1 | 83.5 ± 5.0 | 8.5 ± 1.6 | 94% |
| 6 Months | 9.6 ± 3.0 | 84.5 ± 5.1 | 9.0 ± 1.5 | 94% |
| 12 Months | 9.5 ± 3.0 | 85.5 ± 5.0 | 9.2 ± 1.4 | 93% |
| Group B Baseline | 11.0 ± 4.0 | 78.0 ± 6.0 | 7.0 ± 1.5 | 94% |
| 1 Month | 10.8 ± 3.9 | 79.5 ± 5.8 | 7.5 ± 1.5 | 94% |
| 3 Months | 10.7 ± 3.8 | 80.5 ± 6.0 | 7.8 ± 1.4 | 93% |
| 6 Months | 10.6 ± 3.8 | 80.0 ± 6.0 | 8.0 ± 1.5 | 92% |
| 12 Months | 10.5 ± 3.8 | 80.0 ± 6.5 | 8.2 ± 1.5 | 91% |
| p-value (A vs. B) | 0.06 | 0.03 | 0.04 | 0.05 |